US Patent D878564 Drug delivery implement
Patent D878564 was granted and assigned to MedImmune on March, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent D878564 Drug delivery implement
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.